CA19-9 Antibody

• Catalog Number: orb750179
• Category: Antibodies
• Description: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
• Clonality: Recombinant
• Species/Host: Rabbit
• Isotype: Rabbit IgG, kappa
• Conjugation: Unconjugated
• Reactivity: Human
• Immunogen: Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
• UniProt ID: Not Known
• Tested applications: IHC-P
• Dilution range: Immunohistochemistry (FFPE): 5-10ug/ml for 30 min at RT
• Application notes: Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
• Antibody Type: Primary Antibody
• Clone Number: CA19.9/1390R
• Formula: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Hazard Information: This recombinant CA19-9 antibody is available for research use only.
• Note: For research use only

IHC testing of FFPE human gastric carcinoma with recombinant CA19-9 antibody (clone CA19.9/1390R). HIER: steam sections in pH6 citrate buffer for 10-20 min.

SDS-PAGE Analysis of Purified, BSA-Free Recombinant CA19-9 Antibody (clone CA19.9/1390R). Confirmation of Integrity and Purity of the Antibody.